Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Phage therapy wikipedia , lookup
Bacteriophage wikipedia , lookup
Carbapenem-resistant enterobacteriaceae wikipedia , lookup
Clostridium difficile infection wikipedia , lookup
Human microbiota wikipedia , lookup
Neisseria meningitidis wikipedia , lookup
Bacterial taxonomy wikipedia , lookup
Bacterial cell structure wikipedia , lookup
Innovative oligourea foldamers with antimicrobial effects: application to Bacillus anthracis infection. Stéphanie Antunes1, Céline Douat1, Jean-Philippe Corre2, Pierre Goossens2 and Gilles Guichard*1 1 University of Bordeaux ā CNRS UMR5248, IECB European Institute of Chemistry and Biology, CBMN, 2 2 rue Robert Escarpit, Pessac, France; Laboratories of Pathogenesis of Bacterial Toxi-Infections, Pasteur Institute, Paris, France. The increasing antibiotic resistance among pathogens and the emergence of biological weapons have highlighted the urgent need of new antimicrobial agents. In this context, the design of unnatural oligomers with predictable folding patterns (i.e. foldamers) capable of mimicking the amphiphilic character and conformation of natural antimicrobial peptides, key effector molecules of innate immunity, offers new prospects [1]. Our group is developing peptidomimetic oligomers incorporating ethylene diamine units linked by urea bond ((NH-CH(R)-CH2-NH-CO)n, Figure 1a). These aliphatic oligomers display a strong propensity for helix formation in solution and in the solid state. More particularly, it has been shown that short chain oligoureas (8-mers) display a significant activity in vitro against both Gram-negative and positive bacteria and show some selectivity for bacterial versus eukaryotic cells (eg. OL1, Figure 1b) [2]. Fig 1. a) N, Nā-linked oligourea b) Sequence of the oligourea OL1 designed to adopt a helical amphipathic structure. We have investigated the activities of such foldamers on capsulated and noncapsulated pathogenic bacterium Bacillus anthracis. Early results on structure-activity relationship studies carried out by performing series of modifications on a lead compound (i.e. side-chain replacement, size and backbone modifications) but also therapeutic activities in vivo in animal models will be reported. [1] [2] G. Guichard, I. Huc (2011), Chem. comm. 47, 5933-5941. a) P. Claudon, A. Violette, K. Lamour, M. Decossas, S. Fournel, B. Heurtault, J. Godet, Y. Mély, B. Jamart-Grégoire, M.-C. Averlant-Petit, J.-P. Briand, G. Duportail, H. Monteil, G. Guichard (2010), Angew. Chem. Int. Ed., 49, 333-336; b) A. Violette, S. Fournel, K. Lamour, O. Chaloin, B. Frisch, J.-P. Briand, H. Monteil, G. Guichard (2006), Chem. Biol. 13, 531-538.